Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer
Abstract Objective: Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications. Glucose transporter 1 (GLUT-1) is recognized as a major early marker of...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
MIYAKITA, HIDESHI [verfasserIn] TOKUNAGA, MASATOSI [verfasserIn] ONDA, HAJIME [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
Melbourne, Australia: Blackwell Science Pty ; 2002 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
Online-Ressource |
|---|
| Reproduktion: |
2002 ; Blackwell Publishing Journal Backfiles 1879-2005 |
|---|---|
| Übergeordnetes Werk: |
In: International journal of urology - Oxford [u.a.] : Wiley-Blackwell, 1997, 9(2002), 1, Seite 0 |
| Übergeordnetes Werk: |
volume:9 ; year:2002 ; number:1 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1046/j.1442-2042.2002.00416.x |
|---|
| Katalog-ID: |
NLEJ242669808 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ242669808 | ||
| 003 | DE-627 | ||
| 005 | 20210707162424.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 120427s2002 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1046/j.1442-2042.2002.00416.x |2 doi | |
| 035 | |a (DE-627)NLEJ242669808 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 100 | 1 | |a MIYAKITA, HIDESHI |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer |
| 264 | 1 | |a Melbourne, Australia |b Blackwell Science Pty |c 2002 | |
| 300 | |a Online-Ressource | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Abstract Objective: Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications. Glucose transporter 1 (GLUT-1) is recognized as a major early marker of cellular malignant transformation. The aims of this study were to assess whether FDG-PET is a useful diagnostic tool for renal cell carcinoma and to compare the pathologic characteristics.Methods: Nineteen consecutive patients who had renal cell carcinoma were examined using FDG-PET preoperatively. The results of PET were then compared to the histology obtained after radical surgery and the immunoreactivity of GLUT-1 was also studied.Results: Pathologic examination confirmed that all 19 patients suffered from renal cell carcinoma. Increased FDG uptake was found in six of the 19 patients (31.5%). The immunohistochemical examination of GLUT-1 in renal cell carcinoma produced different results in each patient. There was no correlation with GLUT-1 immunoreactivity and FDG-PET positivity.Conclusion: These results suggest that FDG-PET may not be a useful diagnostic tool for renal cell carcinoma. | ||
| 533 | |d 2002 |f Blackwell Publishing Journal Backfiles 1879-2005 |7 |2002|||||||||| | ||
| 650 | 4 | |a FDG-PET | |
| 700 | 1 | |a TOKUNAGA, MASATOSI |e verfasserin |4 aut | |
| 700 | 1 | |a ONDA, HAJIME |e verfasserin |4 aut | |
| 700 | 1 | |a USUI, YUKIO |4 oth | |
| 700 | 1 | |a KINOSHITA, HIDECHIKA |4 oth | |
| 700 | 1 | |a KAWAMURA, NOBUO |4 oth | |
| 700 | 1 | |a YASUDA, SEIEI |4 oth | |
| 773 | 0 | 8 | |i In |t International journal of urology |d Oxford [u.a.] : Wiley-Blackwell, 1997 |g 9(2002), 1, Seite 0 |h Online-Ressource |w (DE-627)NLEJ243925654 |w (DE-600)2009793-1 |x 1442-2042 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2002 |g number:1 |g pages:0 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1046/j.1442-2042.2002.00416.x |q text/html |x Verlag |z Deutschlandweit zugänglich |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-DJB | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2002 |e 1 |h 0 | ||
| author_variant |
h m hm m t mt h o ho |
|---|---|
| matchkey_str |
article:14422042:2002----::infcnef8furdoylcspstoeisotmgahfgefreetoornlelacnmadmuoitceiag |
| hierarchy_sort_str |
2002 |
| publishDate |
2002 |
| allfields |
10.1046/j.1442-2042.2002.00416.x doi (DE-627)NLEJ242669808 DE-627 ger DE-627 rakwb MIYAKITA, HIDESHI verfasserin aut Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer Melbourne, Australia Blackwell Science Pty 2002 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Objective: Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications. Glucose transporter 1 (GLUT-1) is recognized as a major early marker of cellular malignant transformation. The aims of this study were to assess whether FDG-PET is a useful diagnostic tool for renal cell carcinoma and to compare the pathologic characteristics.Methods: Nineteen consecutive patients who had renal cell carcinoma were examined using FDG-PET preoperatively. The results of PET were then compared to the histology obtained after radical surgery and the immunoreactivity of GLUT-1 was also studied.Results: Pathologic examination confirmed that all 19 patients suffered from renal cell carcinoma. Increased FDG uptake was found in six of the 19 patients (31.5%). The immunohistochemical examination of GLUT-1 in renal cell carcinoma produced different results in each patient. There was no correlation with GLUT-1 immunoreactivity and FDG-PET positivity.Conclusion: These results suggest that FDG-PET may not be a useful diagnostic tool for renal cell carcinoma. 2002 Blackwell Publishing Journal Backfiles 1879-2005 |2002|||||||||| FDG-PET TOKUNAGA, MASATOSI verfasserin aut ONDA, HAJIME verfasserin aut USUI, YUKIO oth KINOSHITA, HIDECHIKA oth KAWAMURA, NOBUO oth YASUDA, SEIEI oth In International journal of urology Oxford [u.a.] : Wiley-Blackwell, 1997 9(2002), 1, Seite 0 Online-Ressource (DE-627)NLEJ243925654 (DE-600)2009793-1 1442-2042 nnns volume:9 year:2002 number:1 pages:0 http://dx.doi.org/10.1046/j.1442-2042.2002.00416.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 9 2002 1 0 |
| spelling |
10.1046/j.1442-2042.2002.00416.x doi (DE-627)NLEJ242669808 DE-627 ger DE-627 rakwb MIYAKITA, HIDESHI verfasserin aut Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer Melbourne, Australia Blackwell Science Pty 2002 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Objective: Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications. Glucose transporter 1 (GLUT-1) is recognized as a major early marker of cellular malignant transformation. The aims of this study were to assess whether FDG-PET is a useful diagnostic tool for renal cell carcinoma and to compare the pathologic characteristics.Methods: Nineteen consecutive patients who had renal cell carcinoma were examined using FDG-PET preoperatively. The results of PET were then compared to the histology obtained after radical surgery and the immunoreactivity of GLUT-1 was also studied.Results: Pathologic examination confirmed that all 19 patients suffered from renal cell carcinoma. Increased FDG uptake was found in six of the 19 patients (31.5%). The immunohistochemical examination of GLUT-1 in renal cell carcinoma produced different results in each patient. There was no correlation with GLUT-1 immunoreactivity and FDG-PET positivity.Conclusion: These results suggest that FDG-PET may not be a useful diagnostic tool for renal cell carcinoma. 2002 Blackwell Publishing Journal Backfiles 1879-2005 |2002|||||||||| FDG-PET TOKUNAGA, MASATOSI verfasserin aut ONDA, HAJIME verfasserin aut USUI, YUKIO oth KINOSHITA, HIDECHIKA oth KAWAMURA, NOBUO oth YASUDA, SEIEI oth In International journal of urology Oxford [u.a.] : Wiley-Blackwell, 1997 9(2002), 1, Seite 0 Online-Ressource (DE-627)NLEJ243925654 (DE-600)2009793-1 1442-2042 nnns volume:9 year:2002 number:1 pages:0 http://dx.doi.org/10.1046/j.1442-2042.2002.00416.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 9 2002 1 0 |
| allfields_unstemmed |
10.1046/j.1442-2042.2002.00416.x doi (DE-627)NLEJ242669808 DE-627 ger DE-627 rakwb MIYAKITA, HIDESHI verfasserin aut Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer Melbourne, Australia Blackwell Science Pty 2002 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Objective: Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications. Glucose transporter 1 (GLUT-1) is recognized as a major early marker of cellular malignant transformation. The aims of this study were to assess whether FDG-PET is a useful diagnostic tool for renal cell carcinoma and to compare the pathologic characteristics.Methods: Nineteen consecutive patients who had renal cell carcinoma were examined using FDG-PET preoperatively. The results of PET were then compared to the histology obtained after radical surgery and the immunoreactivity of GLUT-1 was also studied.Results: Pathologic examination confirmed that all 19 patients suffered from renal cell carcinoma. Increased FDG uptake was found in six of the 19 patients (31.5%). The immunohistochemical examination of GLUT-1 in renal cell carcinoma produced different results in each patient. There was no correlation with GLUT-1 immunoreactivity and FDG-PET positivity.Conclusion: These results suggest that FDG-PET may not be a useful diagnostic tool for renal cell carcinoma. 2002 Blackwell Publishing Journal Backfiles 1879-2005 |2002|||||||||| FDG-PET TOKUNAGA, MASATOSI verfasserin aut ONDA, HAJIME verfasserin aut USUI, YUKIO oth KINOSHITA, HIDECHIKA oth KAWAMURA, NOBUO oth YASUDA, SEIEI oth In International journal of urology Oxford [u.a.] : Wiley-Blackwell, 1997 9(2002), 1, Seite 0 Online-Ressource (DE-627)NLEJ243925654 (DE-600)2009793-1 1442-2042 nnns volume:9 year:2002 number:1 pages:0 http://dx.doi.org/10.1046/j.1442-2042.2002.00416.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 9 2002 1 0 |
| allfieldsGer |
10.1046/j.1442-2042.2002.00416.x doi (DE-627)NLEJ242669808 DE-627 ger DE-627 rakwb MIYAKITA, HIDESHI verfasserin aut Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer Melbourne, Australia Blackwell Science Pty 2002 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Objective: Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications. Glucose transporter 1 (GLUT-1) is recognized as a major early marker of cellular malignant transformation. The aims of this study were to assess whether FDG-PET is a useful diagnostic tool for renal cell carcinoma and to compare the pathologic characteristics.Methods: Nineteen consecutive patients who had renal cell carcinoma were examined using FDG-PET preoperatively. The results of PET were then compared to the histology obtained after radical surgery and the immunoreactivity of GLUT-1 was also studied.Results: Pathologic examination confirmed that all 19 patients suffered from renal cell carcinoma. Increased FDG uptake was found in six of the 19 patients (31.5%). The immunohistochemical examination of GLUT-1 in renal cell carcinoma produced different results in each patient. There was no correlation with GLUT-1 immunoreactivity and FDG-PET positivity.Conclusion: These results suggest that FDG-PET may not be a useful diagnostic tool for renal cell carcinoma. 2002 Blackwell Publishing Journal Backfiles 1879-2005 |2002|||||||||| FDG-PET TOKUNAGA, MASATOSI verfasserin aut ONDA, HAJIME verfasserin aut USUI, YUKIO oth KINOSHITA, HIDECHIKA oth KAWAMURA, NOBUO oth YASUDA, SEIEI oth In International journal of urology Oxford [u.a.] : Wiley-Blackwell, 1997 9(2002), 1, Seite 0 Online-Ressource (DE-627)NLEJ243925654 (DE-600)2009793-1 1442-2042 nnns volume:9 year:2002 number:1 pages:0 http://dx.doi.org/10.1046/j.1442-2042.2002.00416.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 9 2002 1 0 |
| allfieldsSound |
10.1046/j.1442-2042.2002.00416.x doi (DE-627)NLEJ242669808 DE-627 ger DE-627 rakwb MIYAKITA, HIDESHI verfasserin aut Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer Melbourne, Australia Blackwell Science Pty 2002 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract Objective: Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications. Glucose transporter 1 (GLUT-1) is recognized as a major early marker of cellular malignant transformation. The aims of this study were to assess whether FDG-PET is a useful diagnostic tool for renal cell carcinoma and to compare the pathologic characteristics.Methods: Nineteen consecutive patients who had renal cell carcinoma were examined using FDG-PET preoperatively. The results of PET were then compared to the histology obtained after radical surgery and the immunoreactivity of GLUT-1 was also studied.Results: Pathologic examination confirmed that all 19 patients suffered from renal cell carcinoma. Increased FDG uptake was found in six of the 19 patients (31.5%). The immunohistochemical examination of GLUT-1 in renal cell carcinoma produced different results in each patient. There was no correlation with GLUT-1 immunoreactivity and FDG-PET positivity.Conclusion: These results suggest that FDG-PET may not be a useful diagnostic tool for renal cell carcinoma. 2002 Blackwell Publishing Journal Backfiles 1879-2005 |2002|||||||||| FDG-PET TOKUNAGA, MASATOSI verfasserin aut ONDA, HAJIME verfasserin aut USUI, YUKIO oth KINOSHITA, HIDECHIKA oth KAWAMURA, NOBUO oth YASUDA, SEIEI oth In International journal of urology Oxford [u.a.] : Wiley-Blackwell, 1997 9(2002), 1, Seite 0 Online-Ressource (DE-627)NLEJ243925654 (DE-600)2009793-1 1442-2042 nnns volume:9 year:2002 number:1 pages:0 http://dx.doi.org/10.1046/j.1442-2042.2002.00416.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 9 2002 1 0 |
| source |
In International journal of urology 9(2002), 1, Seite 0 volume:9 year:2002 number:1 pages:0 |
| sourceStr |
In International journal of urology 9(2002), 1, Seite 0 volume:9 year:2002 number:1 pages:0 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
FDG-PET |
| isfreeaccess_bool |
false |
| container_title |
International journal of urology |
| authorswithroles_txt_mv |
MIYAKITA, HIDESHI @@aut@@ TOKUNAGA, MASATOSI @@aut@@ ONDA, HAJIME @@aut@@ USUI, YUKIO @@oth@@ KINOSHITA, HIDECHIKA @@oth@@ KAWAMURA, NOBUO @@oth@@ YASUDA, SEIEI @@oth@@ |
| publishDateDaySort_date |
2002-01-01T00:00:00Z |
| hierarchy_top_id |
NLEJ243925654 |
| id |
NLEJ242669808 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ242669808</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707162424.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s2002 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1046/j.1442-2042.2002.00416.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ242669808</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">MIYAKITA, HIDESHI</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Melbourne, Australia</subfield><subfield code="b">Blackwell Science Pty</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Objective: Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications. Glucose transporter 1 (GLUT-1) is recognized as a major early marker of cellular malignant transformation. The aims of this study were to assess whether FDG-PET is a useful diagnostic tool for renal cell carcinoma and to compare the pathologic characteristics.Methods: Nineteen consecutive patients who had renal cell carcinoma were examined using FDG-PET preoperatively. The results of PET were then compared to the histology obtained after radical surgery and the immunoreactivity of GLUT-1 was also studied.Results: Pathologic examination confirmed that all 19 patients suffered from renal cell carcinoma. Increased FDG uptake was found in six of the 19 patients (31.5%). The immunohistochemical examination of GLUT-1 in renal cell carcinoma produced different results in each patient. There was no correlation with GLUT-1 immunoreactivity and FDG-PET positivity.Conclusion: These results suggest that FDG-PET may not be a useful diagnostic tool for renal cell carcinoma.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2002</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2002||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">FDG-PET</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">TOKUNAGA, MASATOSI</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">ONDA, HAJIME</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">USUI, YUKIO</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">KINOSHITA, HIDECHIKA</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">KAWAMURA, NOBUO</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">YASUDA, SEIEI</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International journal of urology</subfield><subfield code="d">Oxford [u.a.] : Wiley-Blackwell, 1997</subfield><subfield code="g">9(2002), 1, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243925654</subfield><subfield code="w">(DE-600)2009793-1</subfield><subfield code="x">1442-2042</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1046/j.1442-2042.2002.00416.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| series2 |
Blackwell Publishing Journal Backfiles 1879-2005 |
| author |
MIYAKITA, HIDESHI |
| spellingShingle |
MIYAKITA, HIDESHI misc FDG-PET Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer |
| authorStr |
MIYAKITA, HIDESHI |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ243925654 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
NL |
| publishPlace |
Melbourne, Australia |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1442-2042 |
| topic_title |
Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer FDG-PET |
| publisher |
Blackwell Science Pty |
| publisherStr |
Blackwell Science Pty |
| topic |
misc FDG-PET |
| topic_unstemmed |
misc FDG-PET |
| topic_browse |
misc FDG-PET |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
y u yu h k hk n k nk s y sy |
| hierarchy_parent_title |
International journal of urology |
| hierarchy_parent_id |
NLEJ243925654 |
| hierarchy_top_title |
International journal of urology |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ243925654 (DE-600)2009793-1 |
| title |
Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer |
| ctrlnum |
(DE-627)NLEJ242669808 |
| title_full |
Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer |
| author_sort |
MIYAKITA, HIDESHI |
| journal |
International journal of urology |
| journalStr |
International journal of urology |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2002 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
MIYAKITA, HIDESHI TOKUNAGA, MASATOSI ONDA, HAJIME |
| container_volume |
9 |
| physical |
Online-Ressource |
| format_se |
Elektronische Aufsätze |
| author-letter |
MIYAKITA, HIDESHI |
| doi_str_mv |
10.1046/j.1442-2042.2002.00416.x |
| author2-role |
verfasserin |
| title_sort |
significance of 18f-fluorodeoxyglucose positron emission tomography (fdg-pet) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (glut-1) expression in the cancer |
| title_auth |
Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer |
| abstract |
Abstract Objective: Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications. Glucose transporter 1 (GLUT-1) is recognized as a major early marker of cellular malignant transformation. The aims of this study were to assess whether FDG-PET is a useful diagnostic tool for renal cell carcinoma and to compare the pathologic characteristics.Methods: Nineteen consecutive patients who had renal cell carcinoma were examined using FDG-PET preoperatively. The results of PET were then compared to the histology obtained after radical surgery and the immunoreactivity of GLUT-1 was also studied.Results: Pathologic examination confirmed that all 19 patients suffered from renal cell carcinoma. Increased FDG uptake was found in six of the 19 patients (31.5%). The immunohistochemical examination of GLUT-1 in renal cell carcinoma produced different results in each patient. There was no correlation with GLUT-1 immunoreactivity and FDG-PET positivity.Conclusion: These results suggest that FDG-PET may not be a useful diagnostic tool for renal cell carcinoma. |
| abstractGer |
Abstract Objective: Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications. Glucose transporter 1 (GLUT-1) is recognized as a major early marker of cellular malignant transformation. The aims of this study were to assess whether FDG-PET is a useful diagnostic tool for renal cell carcinoma and to compare the pathologic characteristics.Methods: Nineteen consecutive patients who had renal cell carcinoma were examined using FDG-PET preoperatively. The results of PET were then compared to the histology obtained after radical surgery and the immunoreactivity of GLUT-1 was also studied.Results: Pathologic examination confirmed that all 19 patients suffered from renal cell carcinoma. Increased FDG uptake was found in six of the 19 patients (31.5%). The immunohistochemical examination of GLUT-1 in renal cell carcinoma produced different results in each patient. There was no correlation with GLUT-1 immunoreactivity and FDG-PET positivity.Conclusion: These results suggest that FDG-PET may not be a useful diagnostic tool for renal cell carcinoma. |
| abstract_unstemmed |
Abstract Objective: Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications. Glucose transporter 1 (GLUT-1) is recognized as a major early marker of cellular malignant transformation. The aims of this study were to assess whether FDG-PET is a useful diagnostic tool for renal cell carcinoma and to compare the pathologic characteristics.Methods: Nineteen consecutive patients who had renal cell carcinoma were examined using FDG-PET preoperatively. The results of PET were then compared to the histology obtained after radical surgery and the immunoreactivity of GLUT-1 was also studied.Results: Pathologic examination confirmed that all 19 patients suffered from renal cell carcinoma. Increased FDG uptake was found in six of the 19 patients (31.5%). The immunohistochemical examination of GLUT-1 in renal cell carcinoma produced different results in each patient. There was no correlation with GLUT-1 immunoreactivity and FDG-PET positivity.Conclusion: These results suggest that FDG-PET may not be a useful diagnostic tool for renal cell carcinoma. |
| collection_details |
GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE |
| container_issue |
1 |
| title_short |
Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer |
| url |
http://dx.doi.org/10.1046/j.1442-2042.2002.00416.x |
| remote_bool |
true |
| author2 |
TOKUNAGA, MASATOSI ONDA, HAJIME USUI, YUKIO KINOSHITA, HIDECHIKA KAWAMURA, NOBUO YASUDA, SEIEI |
| author2Str |
TOKUNAGA, MASATOSI ONDA, HAJIME USUI, YUKIO KINOSHITA, HIDECHIKA KAWAMURA, NOBUO YASUDA, SEIEI |
| ppnlink |
NLEJ243925654 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth |
| doi_str |
10.1046/j.1442-2042.2002.00416.x |
| up_date |
2024-07-06T02:47:24.467Z |
| _version_ |
1803796133412077568 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ242669808</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707162424.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s2002 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1046/j.1442-2042.2002.00416.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ242669808</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">MIYAKITA, HIDESHI</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Melbourne, Australia</subfield><subfield code="b">Blackwell Science Pty</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Objective: Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications. Glucose transporter 1 (GLUT-1) is recognized as a major early marker of cellular malignant transformation. The aims of this study were to assess whether FDG-PET is a useful diagnostic tool for renal cell carcinoma and to compare the pathologic characteristics.Methods: Nineteen consecutive patients who had renal cell carcinoma were examined using FDG-PET preoperatively. The results of PET were then compared to the histology obtained after radical surgery and the immunoreactivity of GLUT-1 was also studied.Results: Pathologic examination confirmed that all 19 patients suffered from renal cell carcinoma. Increased FDG uptake was found in six of the 19 patients (31.5%). The immunohistochemical examination of GLUT-1 in renal cell carcinoma produced different results in each patient. There was no correlation with GLUT-1 immunoreactivity and FDG-PET positivity.Conclusion: These results suggest that FDG-PET may not be a useful diagnostic tool for renal cell carcinoma.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2002</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2002||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">FDG-PET</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">TOKUNAGA, MASATOSI</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">ONDA, HAJIME</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">USUI, YUKIO</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">KINOSHITA, HIDECHIKA</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">KAWAMURA, NOBUO</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">YASUDA, SEIEI</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International journal of urology</subfield><subfield code="d">Oxford [u.a.] : Wiley-Blackwell, 1997</subfield><subfield code="g">9(2002), 1, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243925654</subfield><subfield code="w">(DE-600)2009793-1</subfield><subfield code="x">1442-2042</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1046/j.1442-2042.2002.00416.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.399766 |